img

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
Glucagon Like Peptide-1 (GLP-1) Agonists report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glucagon Like Peptide-1 (GLP-1) Agonists market is projected to reach US$ 21340 million in 2034, increasing from US$ 8816.2 million in 2022, with the CAGR of 13.3% during the period of 2024 to 2034. Demand from Hospital and Pharmacy are the major drivers for the industry.
Market competition is intense. Novo Nordisk, AstraZeneca, Eli Lilly, GSK and Sanofi are the leader of the industry. Novo Nordisk is the top one of this industry by 68% market shares.
United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44%. The second place is Europe, following North America with the production market share of 63% and the consumption market share of 28%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glucagon Like Peptide-1 (GLP-1) Agonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
AstraZeneca
Eli Lily
GSK
Sanofi
Bristol-Myers Squibb
Amylin
Segment by Type
Exenatied
Liraglutide
Lixisenatide
Albiglutide
Dulaglutide

Segment by Application


Hospital
Pharmacy
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Glucagon Like Peptide-1 (GLP-1) Agonists market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glucagon Like Peptide-1 (GLP-1) Agonists, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glucagon Like Peptide-1 (GLP-1) Agonists industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Glucagon Like Peptide-1 (GLP-1) Agonists in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glucagon Like Peptide-1 (GLP-1) Agonists introduction, etc. Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Glucagon Like Peptide-1 (GLP-1) Agonists market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Product Overview
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment by Type
1.2.1 Exenatied
1.2.2 Liraglutide
1.2.3 Lixisenatide
1.2.4 Albiglutide
1.2.5 Dulaglutide
1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Type
1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Type (2018-2034)
1.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size Review by Type (2018-2024)
1.3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2024)
1.4.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Type (2018-2024)
2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Competition by Company
2.1 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Sales (2018-2024)
2.2 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (2018-2024)
2.3 Global Top Players by Glucagon Like Peptide-1 (GLP-1) Agonists Price (2018-2024)
2.4 Global Top Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends
2.5.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2022)
2.7 Date of Key Manufacturers Enter into Glucagon Like Peptide-1 (GLP-1) Agonists Market
2.8 Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glucagon Like Peptide-1 (GLP-1) Agonists Status and Outlook by Region
3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size by Region
3.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2018-2024)
3.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Region (2018-2024)
3.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Region
3.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2024-2034)
3.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Region (2024-2034)
3.3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Glucagon Like Peptide-1 (GLP-1) Agonists by Application
4.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Application
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Overview by Application (2018-2034)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size Review by Application (2018-2024)
4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2024)
4.3.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Breakdown by Application (2018-2024)
5 North America Glucagon Like Peptide-1 (GLP-1) Agonists by Country
5.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size by Country
5.1.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2018-2024)
5.1.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Country (2018-2024)
5.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Country
5.2.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2024-2034)
5.2.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Country (2024-2034)
6 Europe Glucagon Like Peptide-1 (GLP-1) Agonists by Country
6.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size by Country
6.1.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2018-2024)
6.1.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Country (2018-2024)
6.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Country
6.2.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2024-2034)
6.2.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Country (2024-2034)
7 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists by Region
7.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size by Region
7.1.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Region
7.2.1 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Region (2024-2034)
8 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists by Country
8.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size by Country
8.1.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2018-2024)
8.1.3 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Country (2018-2024)
8.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Country
8.2.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2024-2034)
8.2.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Country (2024-2034)
9 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists by Country
9.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Historic Market Size by Country
9.1.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Forecasted Market Size by Country
9.2.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Eli Lily
10.3.1 Eli Lily Company Information
10.3.2 Eli Lily Introduction and Business Overview
10.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
10.3.5 Eli Lily Recent Development
10.4 GSK
10.4.1 GSK Company Information
10.4.2 GSK Introduction and Business Overview
10.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2024)
10.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
10.4.5 GSK Recent Development
10.5 Sanofi
10.5.1 Sanofi Company Information
10.5.2 Sanofi Introduction and Business Overview
10.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
10.5.5 Sanofi Recent Development
10.6 Bristol-Myers Squibb
10.6.1 Bristol-Myers Squibb Company Information
10.6.2 Bristol-Myers Squibb Introduction and Business Overview
10.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
10.6.5 Bristol-Myers Squibb Recent Development
10.7 Amylin
10.7.1 Amylin Company Information
10.7.2 Amylin Introduction and Business Overview
10.7.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Products Offered
10.7.5 Amylin Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
11.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Dynamics
11.4.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
11.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
11.4.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
11.4.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors
12.3 Glucagon Like Peptide-1 (GLP-1) Agonists Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Exenatied
Table 2. Major Company of Liraglutide
Table 3. Major Company of Lixisenatide
Table 4. Major Company of Albiglutide
Table 5. Major Company of Dulaglutide
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2024) & (K Units)
Table 8. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2024) & (US& Million)
Table 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share in Value by Type (2018-2024)
Table 11. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2018-2024) & (USD/Unit)
Table 12. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2034) & (K Units)
Table 13. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type (2024-2034)
Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2024) & (K Units)
Table 18. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2018-2024)
Table 20. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2018-2024)
Table 24. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Company (2018-2024) & (K Units)
Table 28. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Company (2018-2024)
Table 29. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Company (2018-2024)
Table 31. Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Price by Company (2018-2024) & (USD/Unit)
Table 32. Global Glucagon Like Peptide-1 (GLP-1) Agonists Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2022)
Table 35. Date of Key Manufacturers Enter into Glucagon Like Peptide-1 (GLP-1) Agonists Market
Table 36. Key Manufacturers Glucagon Like Peptide-1 (GLP-1) Agonists Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2018-2024) & (K Units)
Table 40. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Region (2018-2024)
Table 43. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 44. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2024-2034) & (K Units)
Table 45. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Region (2024-2034)
Table 48. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) & (K Units)
Table 51. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application (2018-2024)
Table 54. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2018-2024) & (USD/Unit)
Table 55. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2034) & (K Units)
Table 56. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application (2024-2034)
Table 59. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) (K Units)
Table 61. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) (K Units)
Table 63. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) (K Units)
Table 67. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2024) & (K Units)
Table 71. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Country (2018-2024)
Table 74. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2034) & (K Units)
Table 75. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2024) & (K Units)
Table 79. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2034) & (K Units)
Table 83. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Country (2024-2034)
Table 110. Novo Nordisk Company Information
Table 111. Novo Nordisk Introduction and Business Overview
Table 112. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 114. Novo Nordisk Recent Development
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Introduction and Business Overview
Table 117. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 119. AstraZeneca Recent Development
Table 120. Eli Lily Company Information
Table 121. Eli Lily Introduction and Business Overview
Table 122. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 124. Eli Lily Recent Development
Table 125. GSK Company Information
Table 126. GSK Introduction and Business Overview
Table 127. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 129. GSK Recent Development
Table 130. Sanofi Company Information
Table 131. Sanofi Introduction and Business Overview
Table 132. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 134. Sanofi Recent Development
Table 135. Bristol-Myers Squibb Company Information
Table 136. Bristol-Myers Squibb Introduction and Business Overview
Table 137. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 139. Bristol-Myers Squibb Recent Development
Table 140. Amylin Company Information
Table 141. Amylin Introduction and Business Overview
Table 142. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 144. Amylin Recent Development
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
Table 148. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
Table 149. Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
Table 150. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
Table 151. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table 152. Glucagon Like Peptide-1 (GLP-1) Agonists Downstream Customers
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide-1 (GLP-1) Agonists Product Picture
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Exenatied
Figure 6. Global Exenatied Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Liraglutide
Figure 8. Global Liraglutide Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Lixisenatide
Figure 10. Global Lixisenatide Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Albiglutide
Figure 12. Global Albiglutide Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Dulaglutide
Figure 14. Global Dulaglutide Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type in 2022 & 2034
Figure 17. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2022
Figure 18. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2022
Figure 19. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2022
Figure 20. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2022
Figure 23. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucagon Like Peptide-1 (GLP-1) Agonists Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucagon Like Peptide-1 (GLP-1) Agonists Revenue in 2022
Figure 29. Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Hospital
Figure 31. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Pharmacy
Figure 33. Global Pharmacy Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Other
Figure 35. Global Other Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application in 2022 & 2034
Figure 38. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application in 2022
Figure 39. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application in 2022
Figure 40. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application in 2022
Figure 41. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application in 2022
Figure 44. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Glucagon Like Peptide-1 (GLP-1) Agonists Manufacturing Cost Structure
Figure 49. Glucagon Like Peptide-1 (GLP-1) Agonists Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed